RU2001127313A - Конъюгаты жирная кислота-противораковый агент и их применение - Google Patents
Конъюгаты жирная кислота-противораковый агент и их применение Download PDFInfo
- Publication number
- RU2001127313A RU2001127313A RU2001127313/14A RU2001127313A RU2001127313A RU 2001127313 A RU2001127313 A RU 2001127313A RU 2001127313/14 A RU2001127313/14 A RU 2001127313/14A RU 2001127313 A RU2001127313 A RU 2001127313A RU 2001127313 A RU2001127313 A RU 2001127313A
- Authority
- RU
- Russia
- Prior art keywords
- fatty acid
- acid
- conjugate
- taxane
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/265,307 | 1999-03-09 | ||
| US09/265,307 US7235583B1 (en) | 1999-03-09 | 1999-03-09 | Fatty acid-anticancer conjugates and uses thereof |
| US18615200P | 2000-03-01 | 2000-03-01 | |
| US60/186,152 | 2000-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2001127313A true RU2001127313A (ru) | 2003-09-20 |
Family
ID=26881822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2001127313/14A RU2001127313A (ru) | 1999-03-09 | 2000-03-09 | Конъюгаты жирная кислота-противораковый агент и их применение |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1163011A2 (cs) |
| JP (1) | JP2002538224A (cs) |
| KR (1) | KR20020000147A (cs) |
| CN (1) | CN1377282A (cs) |
| AU (1) | AU3733300A (cs) |
| CA (1) | CA2366723C (cs) |
| CZ (1) | CZ20013123A3 (cs) |
| HK (1) | HK1040486A1 (cs) |
| RU (1) | RU2001127313A (cs) |
| WO (1) | WO2000053231A2 (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994392A (en) * | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
| JP2005500988A (ja) * | 2001-03-23 | 2005-01-13 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | 脂肪族アミン薬物複合体 |
| ATE556706T1 (de) * | 2001-03-23 | 2012-05-15 | Luitpold Pharm Inc | Fettalkohol-arzneimittel-konjugate |
| US7169752B2 (en) | 2003-09-30 | 2007-01-30 | New River Pharmaceuticals Inc. | Compounds and compositions for prevention of overdose of oxycodone |
| EP1509256B1 (en) | 2002-05-24 | 2009-07-22 | Angiotech International Ag | Compositions and methods for coating medical implants |
| CA2529125A1 (en) * | 2003-06-19 | 2004-12-23 | Yeda Research & Development Co. Ltd. | Antimicrobial and anticancer lipopeptides |
| AU2004285529A1 (en) * | 2003-10-30 | 2005-05-12 | The Research Foundation of University of New York York | Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
| EP1862183B1 (en) * | 2005-03-14 | 2010-11-03 | Otsuka Pharmaceutical Factory, Inc. | Kit comprising drug and fat emulsion |
| KR100753112B1 (ko) * | 2007-02-26 | 2007-08-29 | (주)고려다이나믹스 | 카드 발권 시스템 |
| BR112015000236A2 (pt) * | 2012-07-10 | 2017-06-27 | Baseclick Gmbh | moléculas de ácidos nucleicos modificadas por anandamida |
| CN117088935A (zh) * | 2022-05-20 | 2023-11-21 | 上海维洱生物医药科技有限公司 | 一种雷公藤甲素木蜡酸酯及其脂质体与制备方法 |
| KR20230174082A (ko) * | 2022-06-20 | 2023-12-27 | (주) 바이오인프라생명과학 | 약물을 전달하기 위한 초음파 감응형 약물전달체를 생성하는 방법 및 이를 이용한 초음파 감응형 약물전달체 |
| CN116676355B (zh) * | 2023-08-03 | 2023-10-24 | 成都第一制药有限公司 | 一种催化合成山莨菪碱的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5925327A (ja) * | 1982-07-31 | 1984-02-09 | Hidematsu Hirai | 抗腫瘍性複合体の製造方法 |
| CA2125279A1 (en) * | 1991-12-10 | 1993-06-24 | John Sayler Coon | Methods and compositions for reducing multi-drug resistance |
| US5925669A (en) * | 1994-03-22 | 1999-07-20 | Molecular/Structural Bio Technologies, Inc. | Carrier compositions for anti-neoplastic drugs |
| US5580899A (en) * | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
| CA2255615C (en) * | 1996-05-22 | 2006-08-29 | Neuromedica, Inc. | Compositions comprising conjugates of cis-docosahexaenoic acid and docetaxel |
| US5919815A (en) * | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
| US5795909A (en) * | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
| US6136988A (en) * | 1998-04-10 | 2000-10-24 | Hauser, Inc. | 7-hexanoyltaxol and methods for preparing the same |
-
2000
- 2000-03-09 CA CA2366723A patent/CA2366723C/en not_active Expired - Fee Related
- 2000-03-09 JP JP2000603720A patent/JP2002538224A/ja active Pending
- 2000-03-09 EP EP00916188A patent/EP1163011A2/en not_active Withdrawn
- 2000-03-09 WO PCT/US2000/006160 patent/WO2000053231A2/en not_active Application Discontinuation
- 2000-03-09 KR KR1020017011387A patent/KR20020000147A/ko not_active Application Discontinuation
- 2000-03-09 CZ CZ20013123A patent/CZ20013123A3/cs unknown
- 2000-03-09 RU RU2001127313/14A patent/RU2001127313A/ru not_active Application Discontinuation
- 2000-03-09 CN CN00804762A patent/CN1377282A/zh active Pending
- 2000-03-09 AU AU37333/00A patent/AU3733300A/en not_active Abandoned
-
2002
- 2002-01-28 HK HK02100653.6A patent/HK1040486A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2366723C (en) | 2011-08-02 |
| AU3733300A (en) | 2000-09-28 |
| JP2002538224A (ja) | 2002-11-12 |
| CA2366723A1 (en) | 2000-09-14 |
| EP1163011A2 (en) | 2001-12-19 |
| KR20020000147A (ko) | 2002-01-04 |
| WO2000053231A3 (en) | 2001-10-04 |
| WO2000053231A2 (en) | 2000-09-14 |
| CN1377282A (zh) | 2002-10-30 |
| CZ20013123A3 (cs) | 2002-03-13 |
| HK1040486A1 (zh) | 2002-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2001127313A (ru) | Конъюгаты жирная кислота-противораковый агент и их применение | |
| US20050101522A1 (en) | Preparation for the prophylaxis of restenosis | |
| ES2657813T3 (es) | Composiciones farmacéuticas para calanolidas, sus derivados y análogos, y proceso para su producción | |
| JP2007509978A (ja) | トコフェロール修飾治療薬化合物 | |
| Koudelka et al. | Liposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo anticancer effect | |
| TW201111382A (en) | Intravenous formulations of neurokinin-1 antagonists | |
| WO2012028101A1 (zh) | 一种难溶性药物的液体组合物及其制备方法 | |
| JP2013501806A5 (cs) | ||
| US20200237707A1 (en) | Pharmaceutical composition for oral administration comprising taxane | |
| JP2016503012A (ja) | 化合物相互作用ドメインを含む製剤及びキャリアシステム | |
| CN112245591A (zh) | 化疗药物-低氧激活前药一体化前药自组装纳米粒的构建 | |
| US6316497B1 (en) | Self-emulsifying systems containing anticancer medicament | |
| CN106946975A (zh) | 一种雷公藤甲素衍生物及其制备方法与制剂 | |
| EP2197492A1 (fr) | Nouvelles compositions a base de taxoides | |
| UA111074C2 (uk) | Композиція, яка містить похідну феніламінопіримідину як активну речовину | |
| US10245234B1 (en) | Method of treating cancer with edible oil derived excipients | |
| AU2004262495A1 (en) | Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids | |
| CN1901901B (zh) | 紫杉醇-脂肪酸结合物及其药物组合物 | |
| US20110082193A1 (en) | Taxane derivative containing pharmaceutical composition with improved therapeutic efficacy | |
| Lee et al. | Stable paclitaxel formulations in oily contrast medium | |
| KR101612257B1 (ko) | 고농도의 탁산을 포함하는 경구 투여용 약학 조성물 | |
| EP2204167A1 (en) | Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules | |
| US20070032438A1 (en) | Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions | |
| US10864280B2 (en) | Nanodroplet compositions for the efficient delivery of anti-cancer agents | |
| CN1875946A (zh) | 10－羟基喜树碱纳米粒及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20050111 |